Advanced search
Publication Cover
Expert Opinion on Investigational Drugs Volume 19, 2010 - Issue 8
Submit an article Journal homepage
358
Views
26
CrossRef citations to date
0
Altmetric
Editorial

Metformin and cancer: licence to heal?

Nikolaos Papanas Outpatient Clinic of Obesity, Diabetes and Metabolism, Second Department of Internal Medicine, Democritus University of Thrace, G Kondyli 22, Alexandroupolis 68100, Greece +30 6977 544337; +30 25510 74723; [email protected]
,
Efstratios Maltezos Outpatient Clinic of Obesity, Diabetes and Metabolism, Second Department of Internal Medicine, Democritus University of Thrace, G Kondyli 22, Alexandroupolis 68100, Greece +30 6977 544337; +30 25510 74723; [email protected]
&
Dimitri P Mikhailidis University College London, University College London Medical School, Royal Free Campus, Department of Clinical Biochemistry (Vascular Disease Prevention Clinics), UK
Pages 913-917 | Published online: 18 Jun 2010

Citations (26)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Fatemeh Sharifzadeh, Soheila Aminimoghaddam, Maryam Kashanian, Masoomeh Fazaeli & Narges Sheikhansari. (2017) A comparison between the effects of metformin and megestrol on simple endometrial hyperplasia. Gynecological Endocrinology 33:2, pages 152-155.
Read now
Isabelle Bourdel-Marchasson, Anja Schweizer & Sylvie Dejager. (2011) Incretin Therapies in the Management of Elderly Patients with Type 2 Diabetes Mellitus. Hospital Practice 39:1, pages 7-21.
Read now

Articles from other publishers (24)

Saira Khan, Su‐Hsin Chang, Amanda A. Seyerle, Mei Wang, Veronica Hicks & Bettina F. Drake. (2023) Post‐diagnostic metformin and statin use and risk of biochemical recurrence in Veterans diagnosed with prostate cancer. The Prostate 83:12, pages 1150-1157.
Crossref
Evanthia Gouveri & Nikolaos Papanas. (2023) Τhe Endless Beauty of Metformin: Does It Also Protect from Skin Aging? A Narrative Review. Advances in Therapy 40:4, pages 1347-1356.
Crossref
Stella Papachristou, Djordje S. Popovic & Nikolaos Papanas. (2022) Reduced Progression of Monoclonal Gammopathy of Undetermined Significance to Multiple Myeloma in Type 2 Diabetes Mellitus: Will Metformin Never Stop Its Pleasant Surprises?. Advances in Therapy 39:6, pages 2283-2286.
Crossref
Saira Khan, Su-Hsin Chang, Veronica Hicks, Mei Wang, Robert L. GrubbIIIIII & Bettina F. Drake. (2021) Improved survival with post-diagnostic metformin and statin use in a racially diverse cohort of US Veterans with advanced prostate cancer. Prostate Cancer and Prostatic Diseases 25:4, pages 707-712.
Crossref
Marwa S. Hamza, Eman Ramadan & Salama A. Salama. (2021) Glucose and fatty acid metabolism involved in the protective effect of metformin against ulipristal-induced endometrial changes in rats. Scientific Reports 11:1.
Crossref
Stella Papachristou & Nikolaos Papanas. (2021) Reduction of Depression in Diabetes: A New Pleiotropic Action of Metformin?. Diabetes Therapy 12:4, pages 965-968.
Crossref
Ahmed Gedawy, Hani Al-Salami & Crispin R Dass. (2020) Role of metformin in various pathologies: state-of-the-art microcapsules for improving its pharmacokinetics. Therapeutic Delivery 11:11, pages 733-753.
Crossref
Saira Khan, Jianwen Cai, Matthew E. Nielsen, Melissa A. Troester, James L. Mohler, Elizabeth T. H. Fontham, Laura Farnan, Bettina F. Drake, Andrew F. Olshan & Jeannette T. Bensen. (2018) The association of metformin use with prostate cancer aggressiveness among Black Americans and White Americans in a population-based study. Cancer Causes & Control 29:11, pages 1143-1150.
Crossref
Amr Ahmed EL-Arabey. (2017) New insight for metformin against bladder cancer. Genes and Environment 39:1.
Crossref
Ntsoaki Annah Nyane, Thabiso Bethwel Tlaila, Tanki Gabriel Malefane, Dudu Edith Ndwandwe & Peter Mark Oroma Owira. (2017) Metformin-like antidiabetic, cardio-protective and non-glycemic effects of naringenin: Molecular and pharmacological insights. European Journal of Pharmacology 803, pages 103-111.
Crossref
Wun-Jae Kim. (2015) Is 5´-AMP-Activated Protein Kinase Both Jekyll and Hyde in Bladder Cancer?. International Neurourology Journal 19:2, pages 55-66.
Crossref
Tack Lee. (2015) Application of Oncology Research to Resolve a Problem in Neurourology. International Neurourology Journal 19:2, pages 53-54.
Crossref
Sukriti Krishan, Des R. Richardson & Sumit Sahni. (2015) Adenosine Monophosphate–Activated Kinase and Its Key Role in Catabolism: Structure, Regulation, Biological Activity, and Pharmacological Activation. Molecular Pharmacology 87:3, pages 363-377.
Crossref
Lilian Beatriz Aguayo Rojas & Marilia Brito Gomes. (2013) Metformin: an old but still the best treatment for type 2 diabetes. Diabetology & Metabolic Syndrome 5:1.
Crossref
José G. Castaño, Carmen González, José A. Obeso & Manuel Rodriguez. 2013. Emerging Drugs and Targets for Parkinson’s Disease. Emerging Drugs and Targets for Parkinson’s Disease 26 57 .
Emmanuel Beck & André J. Scheen. (2013) Quels bénéfices antitumoraux attendre de la metformine ?. Annales d'Endocrinologie 74:2, pages 137-147.
Crossref
S.E. Korsse, M.P. Peppelenbosch & W. van Veelen. (2013) Targeting LKB1 signaling in cancer. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 1835:2, pages 194-210.
Crossref
M.A. Lea. 2013. Bioactive Food as Dietary Interventions for Diabetes. Bioactive Food as Dietary Interventions for Diabetes 291 306 .
Sang-Yong Kim. (2012) Letter: The Risk of Bladder Cancer in Korean Diabetic Subjects Treated with Pioglitazone ( Diabetes Metab J 2012;36:371-8) . Diabetes & Metabolism Journal 36:6, pages 460.
Crossref
Naveed Sattar. 2011. The Metabolic Syndrome. The Metabolic Syndrome 278 296 .
Evanthia Gouveri, Nikolaos Papanas & Efstratios Maltezos. (2011) The female breast and diabetes. The Breast 20:3, pages 205-211.
Crossref
José G. Castaño, Teresa Iglesias & Justo G. de Yébenes. 2011. Animal Models for Neurodegenerative Disease. Animal Models for Neurodegenerative Disease 113 161 .
W van Veelen, S E Korsse, L van de Laar & M P Peppelenbosch. (2011) The long and winding road to rational treatment of cancer associated with LKB1/AMPK/TSC/mTORC1 signaling. Oncogene 30:20, pages 2289-2303.
Crossref
Jason A. Wilken & Nita J. Maihle. (2010) Primary trastuzumab resistance: new tricks for an old drug. Annals of the New York Academy of Sciences 1210:1, pages 53-65.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.